NPPB and COVID-19: Acute myocardial injury, detected by elevated serum levels of cardiac biomarkers, such as cardiac troponin I (cTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), is one of the complications observed in COVID-19 patients.